The judge who approved a $2.4 million settlement in a class action against Carnival said it should be regarded as a victory that cruise passengers got anything, when the case was pleaded at an “unsustainably high level”.
The valuer general has knocked arguments by developer WSTI Properties in a High Court dispute over a heritage property in Melbourne, saying the contentions are “unavailable and unsound”.
EPC Pacific is facing a fight after it got the go-ahead from Yarra City Council to build an 11-storey mixed use office building in an inner city Melbourne suburb.
Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.
Online flight bookings service Webjet has agreed to cop a $9 million penalty for misleading air travelers about prices and bookings, just months after the consumer cop took it to court.
The High Court has been asked to overturn a ruling that found India was immune from a suit seeking to enforce a $111.3 million arbitral award because it did not involve a ‘commercial’ matter.
Melbourne accounting firm Blue Rock has taken its former associate director of accounting to court, claiming she breached her employment contract by making the jump to competitor Nexia.
A former capital partner of HWL Ebsworth wants the High Court to overturn a finding that he was validly expelled from the partnership, arguing the firm’s conduct breached the Equal Opportunity Act.
Munich Reinsurance has been given the OK to bring additional claims in its $696 million lawsuit, which accuses AMP of misleading or deceptive conduct over a quota share agreement.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.